Levobupivacaine Hydrochloride

• Post Date:

  Dec 14,2016

• Expiry Date:

  Jun 12,2017

• Detailed Description:

  Cas No. :27262-48-2 Levobupivacaine Hydrochloride
  Basic Information
  Name: Levobupivacaine hydrochloride
  CAS No.: 27262-48-2
  Formula: C18H29ClN2O
  Molecular Weight: 324.89
  Synonyms: 2-Piperidinecarboxamide,1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (2S)- (9CI);2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride,(S)-;2',6'-Pipecoloxylidide, 1-butyl-, monohydrochloride, (-)- (8CI);(-)-Bupivacaine monohydrochloride;(S)-(-)-Bupivacaine monohydrochloride;Chirocaine;Popscaine;Levobupivacaine HCL
  Melting Point: 254 °C (dec.)(lit.)
  Boiling Point: 423.4 °C at 760 mmHg
  Flash Point: 209.9 °C
  Appearance: white crystalline powder
  Hazard Symbols: VeryT+, HarmfulXn
  Risk Codes: 26/27/28-20/21/22-28
  Safety: 22-36/37/39-45-36/37-53
  Transport Information: UN 2811 6.1/PG 2
  

• CAS Registry Number:

  27262-48-2

• Synonyms:

  ;Timtec-bb sbb001337;(s)-(-)-bupivacaine hcl;(s)-(-)-1-n-butyl-2',6'-dimethyl-2-piperidincarboxanilid hydrochloride;(s)-(-)-1-butyl-2-(2,6-xylylcarbamoyl)-piperidine hydrochloride;s-(-)-1-butyl-2',6'-pipecoloxylidide hydrochloride;(s)-1-butyl-2’,6’-piperidinecarboxamidemonohydrochloride;(s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamidemonohydrochloride;6’-pipecoloxylidide,1-butyl-,hydrochloride,(-)-2 bupicainehydrochloride(-);1-butyl-n-[2,6-dimethylphenyl]-2-piperidinecarboxamide hydrochloride;bupivacaine hydrochloride, monohydrate;levobupivacaine hcl;levobupivacaine hydrochloride;(s)-bupivacaine hcl;s-(-)-1-butyl-2,6-pipecoloxylidide hydrochloride;(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride (1:1);

• Molecular Formula:

  C₁₈H₂₉ClN₂O

• Molecular Weight:

  324.8887

• Molecular Structure:

  

• Hazard Symbols:

   Xn:Harmful;
  

• Risk Codes:

  R20/21/22:;
  

• Safety Description:

  S36/37:;
  

• Company:

  Wuhan Yuancheng Gongchuang Tech. Co.,Ltd     [ China ]        

• Contact:

  helen

• Tel:

  027-50756139

• Fax:

• Email:

  jxc@ycphar.com